Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(rac)-N-{[(3-bromo-6-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}-2-methylpyridin-4-yl)methyl](methyl)-λ4-sulfanylidene}-2,2,2-trifluoroacetamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1610359-07-3

Post Buying Request

1610359-07-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (rac)-N-{[(3-bromo-6-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}-2-methylpyridin-4-yl)methyl](methyl)-λ4-sulfanylidene}-2,2,2-trifluoroacetamide

    Cas No: 1610359-07-3

  • Need to discuss

  • No requirement

  • Adequate

  • Lonwin Chemical Group Limited
  • Contact Supplier
  • (rac)-N-{[(3-bromo-6-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}-2-methylpyridin-4-yl)methyl](methyl)-λ4-sulfanylidene}-2,2,2-trifluoroacetamide

    Cas No: 1610359-07-3

  • Need to discuss

  • No requirement

  • Adequate

  • GL Biochem (Shanghai) Ltd.
  • Contact Supplier

1610359-07-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1610359-07-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,0,3,5 and 9 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1610359-07:
(9*1)+(8*6)+(7*1)+(6*0)+(5*3)+(4*5)+(3*9)+(2*0)+(1*7)=133
133 % 10 = 3
So 1610359-07-3 is a valid CAS Registry Number.

1610359-07-3Relevant articles and documents

5-FLUORO-N-(PYRIDIN-2-YL)PYRIDIN-2-AMINE DERIVATIVES CONTAINING A SULFOXIMINE GROUP

-

, (2014/06/11)

The present invention relates to 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1610359-07-3